Market Tracker

07/23 12:16pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

51.73
Data as of 12:01pm ET
 +2.59 / +5.27%
Today’s Change
36.82
Today|||52-Week Range
80.42
-1.65%
Year-to-Date

Today’s Trading

Previous close49.14
Today’s open49.31
Day’s range49.31 - 52.07
Volume307,726
Average volume (3 months)299,122
Market cap$1.0B
Dividend yield--
Data as of 12:01pm ET, 07/23/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+60.00%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+56.02%
P/E ratio110.1
Price/Sales21.82
Price/Book20.27

Competitors

 Today’s
change
Today’s
% change
USNAUSANA Health Science...-1.72-2.37%
NBIXNeurocrine Bioscienc...+0.22+1.66%
EPZMEpizyme Inc+1.93+6.35%
HZNPHorizon Pharma Inc+0.36+2.56%
Data as of 12:16pm ET, 07/23/2014

Financials

Next reporting dateAugust 4, 2014
EPS forecast (this quarter)$0.12
Annual revenue (last year)$49.0M
Annual profit (last year)$8.8M
Net profit margin18.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John L. Higgins
Chief Operating Officer &
Executive Vice President
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts